Nucleic Acids Research Advance Access published online on September 13, 2007
Nucleic Acids Research, doi:10.1093/nar/gkm662
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Methods Online |
Genomic profiling of CpG methylation and allelic specificity using quantitative high-throughput mass spectrometry: critical evaluation and improvements
Cancer Program, Garvan Institute of Medical Research, 384 Victoria Street, Darlinghurst, Sydney 2010, New South Wales, Australia
*To whom correspondence should be addressed. Tel: +61 2 92958315; Fax: +61 2 92958316; Email: s.clark{at}garvan.org.au
Received June 22, 2007. Revised August 1, 2007. Accepted August 11, 2007.
CpG methylation is a key component of the epigenome architecture that is associated with changes in gene expression without a change to the DNA sequence. Since the first reports on deregulation of DNA methylation, in diseases such as cancer, and the initiation of the Human Epigenome Project, an increasing need has arisen for a detailed, high-throughput and quantitative method of analysis to discover and validate normal and aberrant DNA methylation profiles in large sample cohorts. Here we present an improved protocol using base-specific fragmentation and MALDI-TOF mass spectrometry that enables a sensitive and high-throughput method of DNA methylation analysis, quantitative to 5% methylation for each informative CpG residue. We have determined the accuracy, variability and sensitivity of the protocol, implemented critical improvements in experimental design and interpretation of the data and developed a new formula to accurately measure CpG methylation. Key innovations now permit determination of differential and allele-specific methylation, such as in cancer and imprinting. The new protocol is ideally suitable for detailed DNA methylation analysis of multiple genomic regions and large sample cohorts that is critical for comprehensive profiling of normal and diseased human epigenomes.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. Vikman, R. M. Brena, P. Armstrong, J. Hartiala, C. B. Stephensen, and H. Allayee Functional analysis of 5-lipoxygenase promoter repeat variants Hum. Mol. Genet., December 1, 2009; 18(23): 4521 - 4529. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. W. Tobi, L.H. Lumey, R. P. Talens, D. Kremer, H. Putter, A. D. Stein, P. E. Slagboom, and B. T. Heijmans DNA methylation differences after exposure to prenatal famine are common and timing- and sex-specific Hum. Mol. Genet., November 1, 2009; 18(21): 4046 - 4053. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kim and M. Mrksich Profiling the selectivity of DNA ligases in an array format with mass spectrometry Nucleic Acids Res., October 23, 2009; (2009) gkp827v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. F. Thompson, M. Suzuki, K. W. Lau, and J. M. Greally A pipeline for the quantitative analysis of CG dinucleotide methylation using mass spectrometry Bioinformatics, September 1, 2009; 25(17): 2164 - 2170. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Kristensen and L. L. Hansen PCR-Based Methods for Detecting Single-Locus DNA Methylation Biomarkers in Cancer Diagnostics, Prognostics, and Response to Treatment Clin. Chem., August 1, 2009; 55(8): 1471 - 1483. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Novak, T. J. Jensen, J. C. Garbe, M. R. Stampfer, and B. W. Futscher Stepwise DNA Methylation Changes Are Linked to Escape from Defined Proliferation Barriers and Mammary Epithelial Cell Immortalization Cancer Res., June 15, 2009; 69(12): 5251 - 5258. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. T. Heijmans, E. W. Tobi, A. D. Stein, H. Putter, G. J. Blauw, E. S. Susser, P. E. Slagboom, and L. H. Lumey Persistent epigenetic differences associated with prenatal exposure to famine in humans PNAS, November 4, 2008; 105(44): 17046 - 17049. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Novak, T. Jensen, M. M. Oshiro, G. S. Watts, C. J. Kim, and B. W. Futscher Agglomerative Epigenetic Aberrations Are a Common Event in Human Breast Cancer Cancer Res., October 15, 2008; 68(20): 8616 - 8625. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Camoriano, S. R. Morey Kinney, M. T. Moser, B. A. Foster, J. L. Mohler, D. L. Trump, A. R. Karpf, and D. J. Smiraglia Phenotype-Specific CpG Island Methylation Events in a Murine Model of Prostate Cancer Cancer Res., June 1, 2008; 68(11): 4173 - 4182. [Abstract] [Full Text] [PDF] |
||||





